135 related articles for article (PubMed ID: 8181857)
1. Successful immunotherapy of the highly metastatic murine ESb lymphoma with sensitized CD8+ T cells and IFN-alpha/beta.
Kaido T; Maury C; Schirrmacher V; Gresser I
Int J Cancer; 1994 May; 57(4):538-43. PubMed ID: 8181857
[TBL] [Abstract][Full Text] [Related]
2. Host CD4+ T lymphocytes are required for the synergistic action of interferon-alpha/beta and adoptively transferred immune cells in the inhibition of visceral ESb metastases.
Kaido TJ; Maury C; Gresser I
Cancer Res; 1995 Dec; 55(24):6133-9. PubMed ID: 8521404
[TBL] [Abstract][Full Text] [Related]
3. Sensitized T lymphocytes render DBA/2 beige mice responsive to IFN alpha/beta therapy of Friend erythroleukemia visceral metastases.
Kaido T; Gresser I; Maury C; Maunoury MT; Vignaux F; Belardelli F
Int J Cancer; 1993 May; 54(3):475-81. PubMed ID: 8509222
[TBL] [Abstract][Full Text] [Related]
4. Interaction of IFN alpha/beta with host cells essential to the early inhibition of Friend erythroleukemia visceral metastases in mice.
Gresser I; Kaido T; Maury C; Woodrow D; Moss J; Belardelli F
Int J Cancer; 1994 May; 57(4):604-11. PubMed ID: 8181864
[TBL] [Abstract][Full Text] [Related]
5. Intranasal administration of IFN-alpha/beta inhibits the development of visceral tumor metastases.
Kaido TJ
J Interferon Cytokine Res; 1997 Jan; 17(1):31-6. PubMed ID: 9041469
[TBL] [Abstract][Full Text] [Related]
6. The essential role of endogenous IFN alpha/beta in the anti-metastatic action of sensitized T lymphocytes in mice injected with Friend erythroleukemia cells.
Gresser I; Maury C; Kaido T; Bandu MT; Tovey MG; Maunoury MT; Fantuzzi L; Gessani S; Greco G; Belardelli F
Int J Cancer; 1995 Nov; 63(5):726-31. PubMed ID: 7591292
[TBL] [Abstract][Full Text] [Related]
7. Transfer of long-lasting tumor immunity by immune T cells from MHC congenic mice: migration, survival and tumor-protectivity of cytotoxic donor cells.
Zangemeister-Wittke U; Schirrmacher V
Biotherapy; 1991; 3(4):319-29. PubMed ID: 1786195
[TBL] [Abstract][Full Text] [Related]
8. Host humoral and cellular immune mechanisms in the continued suppression of Friend erythroleukemia metastases after interferon alpha/beta treatment in mice.
Gresser I; Carnaud C; Maury C; Sala A; Eid P; Woodrow D; Maunoury MT; Belardelli F
J Exp Med; 1991 May; 173(5):1193-203. PubMed ID: 2022926
[TBL] [Abstract][Full Text] [Related]
9. Role of cytokines in GVL (ESb lymphoma) and GVHD after adoptive transfer of allogeneic T lymphocytes in mice.
Gresser I; Greco G; Santini SM; Woodrow D; Mecchia M; Parlato S; Logozzi M; Venditti M; Maunoury MT; Belardelli F
J Interferon Cytokine Res; 1998 Sep; 18(9):667-79. PubMed ID: 9781805
[TBL] [Abstract][Full Text] [Related]
10. Specific eradication of micrometastases by transfer of tumour-immune T cells from major-histocompatibility-complex congenic mice.
Schirrmacher V; von Hoegen P; Griesbach A; Schild HJ; Zangemeister-Wittke U
Cancer Immunol Immunother; 1991; 32(6):373-81. PubMed ID: 1826094
[TBL] [Abstract][Full Text] [Related]
11. Importance of cyclophosphamide-induced bystander effect on T cells for a successful tumor eradication in response to adoptive immunotherapy in mice.
Proietti E; Greco G; Garrone B; Baccarini S; Mauri C; Venditti M; Carlei D; Belardelli F
J Clin Invest; 1998 Jan; 101(2):429-41. PubMed ID: 9435316
[TBL] [Abstract][Full Text] [Related]
12. Graft-versus-leukemia reactivity involves cluster formation between superantigen-reactive donor T lymphocytes and host macrophages.
Müerköster S; Wachowski O; Zerban H; Schirrmacher V; Umansky V; Rocha M
Clin Cancer Res; 1998 Dec; 4(12):3095-106. PubMed ID: 9865926
[TBL] [Abstract][Full Text] [Related]
13. Modification of tumor cells by a low dose of Newcastle disease virus. II. Augmented tumor-specific T cell response as a result of CD4+ and CD8+ immune T cell cooperation.
Schild H; von Hoegen P; Schirrmacher V
Cancer Immunol Immunother; 1989; 28(1):22-8. PubMed ID: 2462467
[TBL] [Abstract][Full Text] [Related]
14. Isolation and characterization of a metastatic Eb-like tumor variant highly responsive to interleukin (IL)-2 and to combination cytokine therapy with IL-2/IL-1 beta and IL-1 beta/interferon-alpha/beta.
Gabriele L; Proietti E; Greco G; Venditti M; Gresser I; Schirrmacher V; Von Hoegen P; Testa U; Modesti A; Cianfriglia M
Invasion Metastasis; 1993; 13(3):147-62. PubMed ID: 8112975
[TBL] [Abstract][Full Text] [Related]
15. Anti-tumor effects of interferon in mice injected with interferon-sensitive and interferon-resistant Friend erythroleukemia cells. VIII. Role of the immune system in the inhibition of visceral metastases.
Gresser I; Maury C; Carnaud C; De Maeyer E; Maunoury MT; Belardelli F
Int J Cancer; 1990 Sep; 46(3):468-74. PubMed ID: 2394514
[TBL] [Abstract][Full Text] [Related]
16. Modification of tumor cells by a low dose of Newcastle disease virus. III. Potentiation of tumor-specific cytolytic T cell activity via induction of interferon-alpha/beta.
von Hoegen P; Zawatzky R; Schirrmacher V
Cell Immunol; 1990 Mar; 126(1):80-90. PubMed ID: 2302742
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of Friend leukemia cell visceral metastases by a new monoclonal antibody and role of the immune system of the host in its action.
Sala A; Gresser I; Chassoux D; Maury C; Santodonato L; Eid P; Maunoury MT; Barca S; Cianfriglia M; Belardelli F
Cancer Res; 1992 May; 52(10):2880-9. PubMed ID: 1581903
[TBL] [Abstract][Full Text] [Related]
18. Alpha 1-interferon gene transfer into metastatic Friend leukemia cells abrogated tumorigenicity in immunocompetent mice: antitumor therapy by means of interferon-producing cells.
Ferrantini M; Proietti E; Santodonato L; Gabriele L; Peretti M; Plavec I; Meyer F; Kaido T; Gresser I; Belardelli F
Cancer Res; 1993 Mar; 53(5):1107-12. PubMed ID: 8439955
[TBL] [Abstract][Full Text] [Related]
19. Prolongation of survival of mice bearing the Eb and ESb lymphoma by treatment with interferon inducers alone or in combination with Corynebacterium parvum.
Storch E; Kirchner H; Schirrmacher V
Cancer Immunol Immunother; 1986; 23(3):179-84. PubMed ID: 2431778
[TBL] [Abstract][Full Text] [Related]
20. Murine interferon-alpha1 gene-transduced ESb tumor cells are rejected by host-mediated mechanisms despite resistance of the parental tumor to interferon-alpha/beta therapy.
Rozera C; Mecchia M; Gresser I; Bandu MT; Proietti E; Venditti M; Sestili P; Santini SM; Fais S; Belardelli F; Ferrantini M
Cancer Gene Ther; 1999; 6(3):246-53. PubMed ID: 10359210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
